Nashville start-up IQuity recently asked themselves a key question: “How can we leverage our data science knowledge and disease experience in a bigger way?” After all, the company that Spurlock founded is built on more than a decade of machine learning expertise with genomic data across multiple autoimmune diseases.

The answer was to build the first data analytics platform to help payers – insurance companies, self-insured enterprises, and their Third-Party Administrators – find and fix their addressable autoimmune disease risks. Unlike the genomic blood data that IQuity studied previously, this platform requires only insurance claims data to produce insights that providers can use to positively impact patient care.

Read the Full Article